Patents by Inventor Thomas Sandmann

Thomas Sandmann has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Combination therapy for the treatment of glioblastoma
    Patent number: 10617755
    Abstract: This invention concerns methods of treating a patient diagnosed with glioblastoma comprising administering to said patient a therapy comprising an effective amount of an anti-VEGF antibody and a chemotherapeutic.
    Type: Grant
    Filed: August 27, 2014
    Date of Patent: April 14, 2020
    Assignee: Genentech, Inc.
    Inventors: Carlos Bais, Richard Bourgon, Heidi Phillips, Thomas Sandmann
  • Diagnostic methods and compositions for treatment of glioblastoma
    Patent number: 10456470
    Abstract: The invention provides methods and compositions to detect expression of one or more biomarkers for identifying and treating patients having glioblastomas who are likely to be responsive to VEGF antagonist therapy. The invention also provides kits and articles of manufacture for use in the methods.
    Type: Grant
    Filed: August 28, 2014
    Date of Patent: October 29, 2019
    Assignee: Genentech, Inc.
    Inventors: Carlos Bais, Richard Bourgon, Heidi Phillips, Thomas Sandmann
  • Method of treatment for glioblastoma by administering a VEGF antagonist
    Patent number: 10208355
    Abstract: The invention provides methods and compositions to detect expression of one or more biomarkers for identifying and treating patients having glioblastomas who are likely to be responsive to VEGF antagonist therapy. The invention also provides kits and articles of manufacture for use in the methods.
    Type: Grant
    Filed: November 8, 2016
    Date of Patent: February 19, 2019
    Assignee: Genentech, Inc.
    Inventors: Carlos Bais, Richard Bourgon, Thomas Sandmann
  • DIAGNOSTIC METHODS AND COMPOSITIONS FOR TREATMENT OF GLIOBLASTOMA
    Publication number: 20170051360
    Abstract: The invention provides methods and compositions to detect expression of one or more biomarkers for identifying and treating patients having glioblastomas who are likely to be responsive to VEGF antagonist therapy. The invention also provides kits and articles of manufacture for use in the methods.
    Type: Application
    Filed: November 8, 2016
    Publication date: February 23, 2017
    Inventors: Carlos BAIS, Richard BOURGON, Thomas SANDMANN
  • DIAGNOSTIC METHODS AND COMPOSITIONS FOR TREATMENT OF GLIOBLASTOMA
    Publication number: 20150064178
    Abstract: The invention provides methods and compositions to detect expression of one or more biomarkers for identifying and treating patients having glioblastomas who are likely to be responsive to VEGF antagonist therapy. The invention also provides kits and articles of manufacture for use in the methods.
    Type: Application
    Filed: August 28, 2014
    Publication date: March 5, 2015
    Applicant: Genentech, Inc.
    Inventors: Carlos BAIS, Richard Bourgon, Heidi Phillips, Thomas Sandmann
  • COMBINATION THERAPY FOR THE TREATMENT OF GLIOBLASTOMA
    Publication number: 20150065781
    Abstract: This invention concerns methods of treating a patient diagnosed with glioblastoma comprising administering to said patient a therapy comprising an effective amount of an anti-VEGF antibody and a chemotherapeutic.
    Type: Application
    Filed: August 27, 2014
    Publication date: March 5, 2015
    Applicant: Genentech, Inc.
    Inventors: Carlos BAIS, Richard Bourgon, Heidi Phillips, Thomas Sandmann